What is the maximum recommended daily dose of Compazine (prochlorperazine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Recommended Daily Dose of Compazine (Prochlorperazine)

The maximum recommended daily dose of prochlorperazine (Compazine) is 40 mg per day for adults when used for severe nausea and vomiting. 1

Dosing Guidelines by Indication

For Nausea and Vomiting

  • Standard oral dosing: 5-10 mg 3-4 times daily 2, 1
  • Daily dosages above 40 mg should only be used in resistant cases 1
  • For chemotherapy-induced nausea and vomiting, prochlorperazine is typically administered at 10-20 mg orally 3-4 times daily 2

For Psychiatric Disorders

  • Non-psychotic anxiety: Maximum 20 mg per day, not to exceed 12 weeks of treatment 1
  • Psychotic disorders including schizophrenia:
    • Mild conditions: 5-10 mg 3-4 times daily 1
    • Moderate to severe conditions: Starting at 10 mg 3-4 times daily, with gradual increases 1
    • Optimum dosage for severe disturbances: 100-150 mg daily 1

Special Populations

Pediatric Dosing

  • Not recommended for children under 20 pounds or under 2 years of age 1
  • Weight-based dosing for children with severe nausea and vomiting:
    • 20-29 lbs: 2.5 mg 1-2 times daily (maximum 7.5 mg/day) 1
    • 30-39 lbs: 2.5 mg 2-3 times daily (maximum 10 mg/day) 1
    • 40-85 lbs: 2.5 mg 3 times daily or 5 mg twice daily (maximum 15 mg/day) 1
  • For children with schizophrenia:
    • Ages 2-5: Maximum 20 mg daily 1
    • Ages 6-12: Maximum 25 mg daily 1

Elderly Patients

  • Dosage should be increased more gradually in elderly patients 1
  • Lower starting doses are recommended due to increased risk of side effects 1

Safety Considerations

Common Side Effects

  • Sedation is common (10% in multiple-dose studies) 3
  • Extrapyramidal symptoms (EPS) occur in approximately 4-9% of patients 3
  • Higher doses increase risk of hypotension and extrapyramidal reactions 4

Serious Adverse Events

  • Repeated doses can potentially prolong QT interval 5
  • Rare but serious adverse events include seizures, neuroleptic malignant syndrome, and tardive dyskinesia 3
  • Fatal outcomes have been reported in pediatric patients, though rarely 3

Clinical Pearls

  • When treating refractory nausea, consider adding a serotonin antagonist (e.g., ondansetron) if prochlorperazine alone is insufficient 2, 5
  • For persistent symptoms, consider opioid rotation or adding another agent class 2
  • Intravenous administration (2.5-5 mg) has been shown to control vomiting in approximately 8.5 minutes, faster than intramuscular administration 6
  • The maximum tolerated dose in cancer chemotherapy studies was found to be 1.2 mg/kg IV, with dose-limiting toxicity being hypotension 4

Monitoring Recommendations

  • Monitor for extrapyramidal symptoms, particularly with higher doses 3, 4
  • Watch for signs of sedation, which may affect patient safety 3
  • Be vigilant for hypotension, especially with intravenous administration 4

Remember that while the absolute maximum daily dose can be higher for psychiatric indications, the standard maximum for nausea and vomiting is 40 mg per day, with careful monitoring required if exceeding this dose 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

A dose finding study of prochlorperazine as an antiemetic for cancer chemotherapy.

European journal of cancer & clinical oncology, 1989

Guideline

Antiemetic Therapy with Prochlorperazine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.